Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "Bharat"

391 News Found

Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project


BSV standardises on Veeva Vault PromoMats to speed content distribution
Digitisation | March 25, 2022

BSV standardises on Veeva Vault PromoMats to speed content distribution

Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials


Covovax for teens get DCGI nod
Drug Approval | March 23, 2022

Covovax for teens get DCGI nod

It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D


IHL launches first zero assistance integrated health centre
Public Health | March 23, 2022

IHL launches first zero assistance integrated health centre

The first-of-its-kind unique centre will increase access to preventive & primary care


Community approach crucial to stamp out diseases
Public Health | March 17, 2022

Community approach crucial to stamp out diseases

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges


BSV invests in solar power project as part of it sustainability commitment
Sustainability | March 16, 2022

BSV invests in solar power project as part of it sustainability commitment

This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years


Applications for PLI in bulk drugs extended till March 31st 2022
News | March 14, 2022

Applications for PLI in bulk drugs extended till March 31st 2022

A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore


Industry seeks favourable policy for India to move up the pharma value chain globally
Policy | February 27, 2022

Industry seeks favourable policy for India to move up the pharma value chain globally

N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry


8 bulk drugs projects commissioned under PLI scheme
News | February 26, 2022

8 bulk drugs projects commissioned under PLI scheme

The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa


Mandaviya launches ICMR/ DHR policy on biomedical innovation & entrepreneurship
Policy | February 25, 2022

Mandaviya launches ICMR/ DHR policy on biomedical innovation & entrepreneurship

This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country